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Evaluate the influence of the total number of counts
acquired from myocardium, in the calculation of myocardial
functional parameters (LVEF – left ventricular ejection
fraction, EDV – end-diastolic volume, ESV – end-sistolic
volume) using routine software procedures.
Gated-SPET studies were simulated using Monte Carlo GATE
package4 and NURBS-based cardiac-torso (NCAT) phantom5.
Figure 1. NCAT phantom (left); simulated images (above) 5.
This was done taking into account the recommendations
made by national European regulatory authorities, national
societies and the EANM Guidelines1 with respect to injected
activities for 99mTc-labelled tracers for adults of normal
weight.
Table 1. Reference values for a normal patient, suggested by EANM Guidelines: Whole
body activity (MBq), corresponding myocardium activity (MBq) and myocardium voxel
activity (≈ myocardium activity / 11005 voxels) 1,6.
Tomographic studies for all myocardium activities (Table 1)
were simulated with 72 projections, including 8 intervals/
cardiac cycle in an 202.5° angle, starting in right anterior
oblique and ending in left posterior oblique view, within the
time period recommended in the Gated-SPECT studies
protocol in HPP–MM7, with 15 and 30 sec/projection. All
simulations were repeated five times.
Simulated data were reconstructed and processed using the
commercial software package Quantitative Gated-SPET to
obtain the functional parameters.
Bland-Altman and Mann-Whitney-Wilcoxon tests were used.
The total number of counts per simulation doesn’t significantly
interfere with the determination of Gated-SPET functional
parameters (LVEF, EDV and ESV) using the administered average
activity of 450 MBq corresponding to 5.4 MBq in myocardium.
Myocardial Perfusion Gated Single Photon Emission
Tomography (Gated-SPET) imaging is used for the
combined evaluation of myocardial perfusion and left
ventricular (LV) function. But standard protocols of the
Gated-SPECT studies require long acquisition times for
each study 1,2,3. It is therefore important to reduce as much
as possible the total duration of image acquisition.
However, it is known that this reduction leads to decrease
on counts statistics per projection and raises doubts about
the validity of the functional parameters determined by
Gated-SPECT.
Considering that, it’s difficult to carry out this analysis in
real patients. For ethical, logistical and economical matters,
simulated studies could be required for this analysis.
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in the determination of reproducible functional parameters 
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Table 2. N.º of total counts in studies with different activities in myocardium and
acquisition times by projection.
Based on the average counts per pixel and average
number of total counts in the myocardium (Table 2) the
functional parameters of the LV myocardium were
obtained to evaluate if they have differences between the
values of LVEF, EDV and ESV (Tables 3, 4, 5).
a Mean±SD LVEF (%) in each 5 simulations with the activity in myocardium of 3, 4.2, 5.4 and 8.2 MBq and with 15sec/projection;
b Mean±SD LVEF (%) in each 5 simulations with the activity in myocardium of 3, 4.2, 5.4 and 8.2 MBq and with 30sec/projection;
c Average LVEF (%) with different times/projections, i.e. (a+b)/2 or (b+c)/2;
d Difference between the values of LVEF(%) simulated with different times/projections, i.e. (a-b) or (b-c).
* Statistically significant differences for p<0.05.
a Mean±SD EDV in each 5 simulations with the activity in myocardium of 3, 4.2, 5.4, and 8.2 MBq and with 15sec/projection;
b Mean±SD EDV in each 5 simulations with the activity in myocardium of 3, 4.2, 5.4 and 8.2 MBq and with 30sec/projection;
c Average EDV with different times/projections, i.e. (a+b)/2 or (b+c)/2;
d Difference between the values of EDV simulated with different times/projections, i.e. (a-b) or (b-c).
* Statistically significant differences for p<0.05.
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REFERENCES
Activity in 
myocardium seconds/ 
projection
Total counts/pixel in 
myocardium (N=5)
Total counts in 
myocardium (N=5)
(MBq) Mean±SD Mean±SD
3.0 15 10.5±2.3 3.20521E+5±71930 21.0±3.1 6.42277E+5±950
4.2 15 14.5±1.5 4.49754E+5±67130 25.0±2.6 8.99812E+5±948
5.4 15 19.5±2.5 5.84315E+5±76430 35.7±3.3 11.64923E+5±1079
8.2 15 23.5±2.5 8.74780E+5±93530 55.5±4.1 17.52107E+5±1320
LVEF
Activity in 
myocardium (MBq)
a15sec. b30sec. cMean dDIF Mean difference±1.96SD
p 
value
3.0 45.6±1.44 48.2±1.06 46.9 -2.6 ±2.10 0.01*
4.2 47.6±0.89 46.0±0.00 46.8 1.6 ±0.90 0.05
5.4 50.4±0.55 49.6±0.55 50.0 0.8 ±1.00 0.06
8.2 50.4±0.80 49.6±0.55 50.0 0.8 ±1.00 0.59
EDV
Activity in 
myocardium (MBq)
a15sec. b30sec. cMean dDIF Mean difference±1.96SD
p 
value
3.0 91.2±1.16 90.6±1.65 90.9 0.6 ±1.65 0.53
4.2 92.0±1.22 88.8±0.45 90.4 3.2 ±1.61 0.01*
5.4 91.4±0.45 90.4±0.67 90.9 1.0 ±1.07 0.05
8.2 90.2±0.45 90.6±0.71 90.3 -0.4 ±0.44 0.14
a Mean±SD ESV in each 5 simulations with the activity in myocardium of 3, 4.2, 5.4 and 8.2 MBq and with 15sec/projection;
b Mean±SD ESV in each 5 simulations with the activity in myocardium of 3, 4.2, 5.4 and 8.2 MBq and with 30sec/projection;
c Average ESV with different times/projections, i.e. (a+b)/2 or (b+c)/2;
d Difference between the values of ESV simulated with different times/projections, i.e. (a-b) or (b-c).
* Statistically significant differences for p<0.05.
ESV
Activity in 
myocardium (MBq)
a15sec. b30sec. cMean dDIF Mean difference±1.96SD
p 
value
3.0 49.2±1.66 46.8±1.77 48.0 2.4 ±2.46 0.03*
4.2 48.4±0.55 48.0±0.71 48.2 0.4 ±1.12 0.34
5.4 45.8±0.55 45.4±0.61 45.6 0.4 ±0.82 0.22
8.2 48.2±0.65 48.6±0.45 48.4 -0.4 ±1.28 0.42
Injected activity
(MBq)
Myocardium activity
(1.2% of whole body activity)
(MBq)
Activity at voxel Myocardium
(≈ Bq / voxel)
250 3.0 275
350 4.2 385
450 5.4 500
680 8.2 750
Table 3. Influence of the count’s number in the values of left ventricular ejection fraction.
Table 4. Influence of the count’s number in the values of end-diastolic volume.
Table 5. Influence of the count’s number in the values of end-sistolic volume.
